Lack of association between polymorphism in ABCC2 gene and response to antiepileptic drug treatment in Croatian patients with epilepsy;Nedostatak povezanosti polimorfizma gena ABCC2 i terapijskog odgovora na antiepileptike kod bolesnika sa epilepsijom u Hrvatskoj

Collegium Antropologicum

Volumn 37, Issue 1, 2013, Pages 41-45

  Sporiš, Davor ^a   Božina, Nada ^b   Bašić, Silvio ^a   Lovrić, Mila ^b   Babić, Tomislav ^c   Šušak, Ivana ^a   Marković, Ivana ^a  

^a University of Zagreb   (Croatia)

^b KBC Zagreb   (Croatia)

^c CNS Scientific Affairs   (United Kingdom)

Author keywords

ABCC2 gene; Cryptogenic; Epilepsy; Genetic polymorphism; Multi drug resistance

Indexed keywords

ANTICONVULSIVE AGENT; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CROATIA; CROSS-SECTIONAL STUDY; EPILEPSY; EXON; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; MULTIDRUG RESISTANCE; PATHOLOGY; PHARMACOGENETICS; PHYSIOLOGY; TEMPORAL LOBE EPILEPSY;

ADOLESCENT; ADULT; AGED; ALLELES; ANTICONVULSANTS; CROATIA; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, MULTIPLE; EPILEPSY; EPILEPSY, COMPLEX PARTIAL; EXONS; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PHARMACOGENETICS; POLYMORPHISM, GENETIC; YOUNG ADULT;

EID: 84876003050     PISSN: 03506134     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. BROWNE TR, HOLMES GL, N Engl J Med, 344 (2001) 1145, DOI: 10.1056/NEJM200104123441507.
2. KWAN P, BRODIE MJ, N Engl J Med, 342 (2000) 314. DOI: 10.1056/NEJM200002033420503.
3. SPERLING MR, CNS Spectr, 9 (2004) 98.
4. SISODIYA SM, Curr Opin Neurol, 16 (2003) 197. DOI: 10.1097/00019052-200304000-00013.
5. BAČIĆ BARONICA K, MLINAC K, OZRETIĆ D, VLADIĆ A, KALANJ BOGNAR S, Coll Antropol, 35 (2011) 11.
6. LOZIĆ B, PRIMORAC D, GLAVINIĆ R, KUZMANIĆ ŠAMIJA R, ZEMUNIK T, Coll Antropol, 35 (2011) 385.
7. ŠMALCELJ A, SERTIĆ J, GOLUBIĆ K, JURČIĆ LJ, BRIDA M, Coll Antropol, 33 (2009) 933.
8. TISHLER DM, WEINBERG KI, HINTON DR, BARBARO N, ANNETT GM, RAFFEL C, Epilepsia, 36 (1995) 1. DOI: 10.1111/j.1528-1157.1995.tb01657.x.
9. SISODIYA SM, HEFFERNAN J, SQUIER MV, Neuroreport, 10 (1999) 3437. DOI: 10. 1097/00001756-199911080-00032.
10. DOMBROWSKI SM, DESAI SY, MARRONI M, CUCULLO L, GOODRICH K, BINGAMANW, MAYBERG MR, BENGEZ L, JANIGRO D, Epilepsia, 42 (2001) 1501. DOI: 10.1046/j. 1528-1157.2001.12301.x.
11. SISODIYA SM, LIN WR, HARDING BN, SQUIER MV, THOM M, Brain, 125 (2002) 22. DOI: 10.1093/brain/awf 002.
12. ARONICA E, GORTER JA, JANSEN GH, VAN VEELEN CW, VAN RIJEN PC, LEENSTRA S, RAMKEMA M, SCHEFFER GL, SCHEPER RJ, TROOST D, Neuroscience, 118 (2003) 417. DOI: 10.1016/S0306-4522(02)00992-2.
13. ARONICA E, GORTER JA, RAMKEMA M, REDEKER S, OZBAS-GERCEKER F, VAN VLIET EA, SCHEFFER GL, SCHEPER RJ, VAN DER VALK P, BAAYEN JC, TROOST D, Epilepsia, 45 (2004) 441. DOI: 10.1111/j.0013-9580.2004.57703.x.
14. ABBOTT NJ, KHAN EU, ROLLINSON CM, REICHEL A, JANIGRO D, DOMBROWSKI SM, DOBBIE MS, BEGLEY DJ, Drug resistance in epilepsy: the role of blood-brain barrier. In: Mechanisms of Drug Resistance in Epilepsy: Lessons from Oncology (Wiley, Chichester, 2002), DOI: 10.1002/0470846356.ch4.
15. SCHINKEL AH, WAGENAAR E, MOL CA, VAN DEEMTER L, J Clin Invest, 97 (1996) 2517. DOI: 10.1172/JCI118699.
16. POTSCHKA H, LÖSCHER W, Epilepsia, 42 (2001) 1231. DOI: 10. 1046/j.1528-1157.2001.01901.x.
17. POTSCHKA H, FEDROWITZ M, LÖSCHER W, Neuroreport, 12 (2001) 3557. DOI: 10.1097/00001756-200111160-00037.
18. POTSCHKA H, FEDROWITZ M, LÖSCHER W, Neurosci Lett, 327 (2002) 173. DOI: 10.1016/S0304-3940(02)00423-8.
19. RIZZI M, CACCIA S, GUISO G, RICHICHI C, GORTER JA, ARONICA E, ALIPRANDI M, BAGNATI R, FANELLI R, D'INCALCI M, SAMANIN R, VEZZANI A, J Neurosci, 22 (2002) 5833.
20. SILLS GJ, KWAN P, BUTLER E, DE LANGE EC, VAN DER BERG DJ, BRODIE MJ, Epilepsy Behav, 3 (2002) 427. DOI: 10.1016/S1525-5050(02)00511-5.
21. POTSCHKA H, FEDROWITZ M, LÖSCHER W, J Pharmacol Exp Ther, 306 (2003) 124. DOI: 10.1124/jpet.103.049858.
22. KERB R, HOFFMEYER S, BRINKMANN U, Pharmacogenomics, 2 (2001) 51, DOI: 10.1517/14622416.2.1.51.
23. SAITO S, IIDA A, SEKINE A, MIURA Y, OGAWA C, KAWAUCHI S, HIGUCHI S, NAKAMURA Y, J Hum Genet, 47 (2002) 147. DOI: 10.1007/s100380200018.
24. MARZOLINI C, TIRONA RG, KIM RB, Pharmacogenomics, 5 (2004) 273. DOI: 10. 1517/phgs.5.3.273.29831.
25. CHOI JH, AHN BM, YI J, LEE JH, LEE JH, NAM SW, CHON CY, HAN KH, AHN SH, JANG IJ, CHO JY, SUH Y, CHO MO, LEE JE, KIM KH, LEE MG, Pharmacogenet Genomics, 17 (2007) 403. DOI: 10.1097/01.fpc.0000236337.41799.b3.
26. DALY AK, AITHAL GP, LEATHART JB, SWAINSBURY RA, DANG TS, DAY CP, Gastroenterology, 132 (2007) 272. DOI: 10.1053/j.gastro.2006.11.023.
27. HAN JY, LIM HS, YOO YK, SHIN ES, PARK YH, LEE SY, LEE JE, LEE DH, KIM HT, LEE JS, Cancer 110 (2007) 138. DOI: 10.1002/cncr. 22760.
28. NAESENS M, KUYPERS DR, VERBEKE K, VANRENTERGHEM Y, Transplantation, 82 (2006) 1074. DOI: 10.1097/01.tp.0000 235533.29300.e7.
29. HAENISCH S, MAY K, WEGNER D, CALIEBE A, CASCORBI I, SIEGMUND W, Pharmacogenet Genomics, 18 (2008) 357, DOI: 10.1097/FPC.0b013e3282f974b7.
30. IZZEDINE H, HULOT JS, VILLARD E, GOYENVALLE C, DOMINGUEZ S, GHOSN J, VALANTIN MA, LECHAT P, DERAY AG, J Infect Dis, 194 (2006) 1481, DOI: 10.1086/508546.
31. MOR-COHEN R, ZIVELIN A, ROSENBERG N, SHANI M, MUALLEM S, SELIGSOHN U, J Biol Chem, 276 (2001) 36923. DOI: 10.1074/jbc.M105047200.
32. GUO SW, THOMPSON EA, Biometrics, 4 (1992) 361.
33. SLATKIN M, EXCOFFIER L, Heredity, 76 (1996) 377. DOI: 10.1038/hdy.1996.55.
34. EXCOFFIER L, LAVAL G, SCHNEIDER S, Evol Bioinform Online, 1 (2005) 47.
35. REGESTA G, TANGANELLI P, Epilepsy Res, 34 (1999) 109. DOI: 10.1016/S0920-1211(98)00106-5.
36. POTSCHKA H, LÖSCHER W, Neuroreport, 12 (2001) 2387. DOI: 10.1097/00001756-200108080-00020.
37. POTSCHKA H, FERDOWITZ M; LÖSCHER W, Epilepsia, 44 (2003) 1479. DOI: 10.1111/j.0013-9580.2003.22603.x.
38. WRIGHT AW, DICKINSON RG, J Pharmacol Exp Ther, 310 (2004) 584. DOI: 10.1124/jpet.103. 064220.
39. BALTES S, FEDROWITZ M, TORTOS CL, POTSCHKA H, LÖSCHER W, J Pharmacol Exp Ther, 320 (2007) 331. DOI: 10.1124/jpet.106.102491.
40. KWAN P, BRODIE MJ, CNS Spectr 9 (2004) 110.
41. KWAN P, BRODIE MJ, Seizure, 9 (2000) 464. DOI: 10.1053/seiz. 2000.0442.
42. SEO T, ISHITSU T, ONIKI K, ABE T, SHUTO T, NAKAGAWA K, J Pharm Pharmacol, 60 (2008) 631. DOI: 10.1211/jpp.60. 5.0009.
43. KIM DW, LEE SK, CHU K, JANG IJ, YU KS, CHO JY, KIM SJ, Epilepsy Res, 84 (2009) 86. DOI: 10.1016/j.eplepsyres.2008.12.001.
44. KWAN P, WONG V, NG PW, LUI CH, SIN NC, WONG KS, BAUM L, Pharmacogenomics, 12 (2011) 319. DOI: 10.2217/pgs.10.183.
45. UFER M, MOSYAGIN I, MUHLE H, JACOBSEN T, HAENISCH S, HÄSLER R, FALTRACO F, REMMLER C, VON SPICZAK S, KROEMER HK, RUNGE U, BOOR R, STEPHANI U, CASCORBI I, Pharmacogenet Genomics, 19 (2009) 353. DOI: 10.1097/FPC.0b013e328329940b.